BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 21458112)

  • 1. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II.
    Guillon J; Mouray E; Moreau S; Mullié C; Forfar I; Desplat V; Belisle-Fabre S; Pinaud N; Ravanello F; Le-Naour A; Léger JM; Gosmann G; Jarry C; Déléris G; Sonnet P; Grellier P
    Eur J Med Chem; 2011 Jun; 46(6):2310-26. PubMed ID: 21458112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity.
    Guillon J; Moreau S; Mouray E; Sinou V; Forfar I; Fabre SB; Desplat V; Millet P; Parzy D; Jarry C; Grellier P
    Bioorg Med Chem; 2008 Oct; 16(20):9133-44. PubMed ID: 18819813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.
    Guillon J; Grellier P; Labaied M; Sonnet P; Léger JM; Déprez-Poulain R; Forfar-Bares I; Dallemagne P; Lemaître N; Péhourcq F; Rochette J; Sergheraert C; Jarry C
    J Med Chem; 2004 Apr; 47(8):1997-2009. PubMed ID: 15055999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines.
    Jonet A; Guillon J; Mullie C; Cohen A; Bentzinger G; Schneider J; Taudon N; Hutter S; Azas N; Moreau S; Savrimoutou S; Agnamey P; Dassonville-Klimpt A; Sonnet P
    Med Chem; 2018; 14(3):293-303. PubMed ID: 28745231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives.
    Mwande Maguene G; Lekana-Douki JB; Mouray E; Bousquet T; Grellier P; Pellegrini S; Toure Ndouo FS; Lebibi J; Pélinski L
    Eur J Med Chem; 2015 Jan; 90():519-25. PubMed ID: 25486423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
    Blackie MA; Beagley P; Croft SL; Kendrick H; Moss JR; Chibale K
    Bioorg Med Chem; 2007 Oct; 15(20):6510-6. PubMed ID: 17693090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
    Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
    Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of pyrido quinoxalines as new family of antimalarial agents.
    Chandra Shekhar A; Shanthan Rao P; Narsaiah B; Allanki AD; Sijwali PS
    Eur J Med Chem; 2014 Apr; 77():280-7. PubMed ID: 24650715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trioxaferroquines as new hybrid antimalarial drugs.
    Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
    J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents.
    Primas N; Suzanne P; Verhaeghe P; Hutter S; Kieffer C; Laget M; Cohen A; Broggi J; Lancelot JC; Lesnard A; Dallemagne P; Rathelot P; Rault S; Vanelle P; Azas N
    Eur J Med Chem; 2014 Aug; 83():26-35. PubMed ID: 24946216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents.
    Gil A; Pabón A; Galiano S; Burguete A; Pérez-Silanes S; Deharo E; Monge A; Aldana I
    Molecules; 2014 Feb; 19(2):2166-80. PubMed ID: 24552985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
    Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
    Biot C; Glorian G; Maciejewski LA; Brocard JS
    J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A; Maurel S; Deharo E; Jullian V; Sauvain M
    Arzneimittelforschung; 2005; 55(12):754-61. PubMed ID: 16430030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents.
    Vicente E; Lima LM; Bongard E; Charnaud S; Villar R; Solano B; Burguete A; Perez-Silanes S; Aldana I; Vivas L; Monge A
    Eur J Med Chem; 2008 Sep; 43(9):1903-10. PubMed ID: 18215443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates.
    Ferreira CL; Ewart CB; Barta CA; Little S; Yardley V; Martins C; Polishchuk E; Smith PJ; Moss JR; Merkel M; Adam MJ; Orvig C
    Inorg Chem; 2006 Oct; 45(20):8414-22. PubMed ID: 16999442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098.
    Kurz T; Schlüter K; Kaula U; Bergmann B; Walter RD; Geffken D
    Bioorg Med Chem; 2006 Aug; 14(15):5121-35. PubMed ID: 16679022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the role of the covalent linkage of ferrocene into a chloroquine template.
    Biot C; Daher W; Ndiaye CM; Melnyk P; Pradines B; Chavain N; Pellet A; Fraisse L; Pelinski L; Jarry C; Brocard J; Khalife J; Forfar-Bares I; Dive D
    J Med Chem; 2006 Jul; 49(15):4707-14. PubMed ID: 16854077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II.
    Desplat V; Moreau S; Gay A; Fabre SB; Thiolat D; Massip S; Macky G; Godde F; Mossalayi D; Jarry C; Guillon J
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):204-15. PubMed ID: 20222763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.